model of an influenza epidemic with drug resistance. J Theor Biol 248: 1793. 54. Moghadas S, Bowman C, Rost G, Wu J Population-wide emergence of antiviral resistance during pandemic influenza. PLoS ONE 3: e1839. 55. Moghadas SM Management of drug resistance in the population: influenza as a 
case study. Proc Biol Sci 275: 1163169. 56. Medlock J, Meyers LA, Galvani A Optimizing allocation for a delayed influenza vaccination campaign. PLoS Curr Influenza: RRN1134. 57. Medlock J, Galvani AP Optimizing influenza vaccine distribution. Science 325: 1705708. 58. Australia Post Annual Report 20089. Technical report, Australia Post. 59. Thorn F Public health emergency order. Victoria Government Gazette S175. 60. Kmietowicz Z England to launch special flu service next week to take pressure off primary care. Br Med J 339: b2932. 61. Lee VJ, Lye DC, Wilder-Smith A Combination strategies for pandemic influenza 1215493-56-3 response – a systematic review of mathematical modeling studies. BMC Medicine 7: 76. 62. Kamigaki T, Oshitani H Epidemiological characteristics and low case fatality rate of pandemic 2009 in Japan. PLoS Curr Influenza: RRN1139. 63. Cowling BJ, Lau EHY, Ip DKM, Ho LM, Tsang T, et al. School closure and mitigation of pandemic 2009, Hong Kong. Emerg Infect Dis 16: 53841. 10 February 2011 | Volume 6 | Issue 2 | e14505 Evidence for OTUD-6B Participation in B Lymphocytes Cell Cycle after Cytokine Stimulation Zhongping Xu1,4, Yufang Zheng2, Yufei Zhu1,4, Xiangyin Kong1,3,4, Landian Hu1,3,4 1 The Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, 2 Department of Physiology and Biophysics, School of Life Sciences, Fudan University, Shanghai, People’s Republic of China, 3 State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, People’s Republic of China, 4 Graduate School of the Chinese Academy of Sciences, Beijing, People’s Republic of China Abstract Deubiquitinating enzymes are important regulators of cell proliferation. Here we identified a functional deubiquitinating enzyme, ovarian tumor domain-containing 6B. Mutation of the conserved Cys residue abolished its deubiquitinating activity in vitro. Otud-6b expression was induced with cytokine stimulation in both mouse Ba/ F3 cells and primary B lymphocytes followed a rapid decrease. This rapid decrease was partially facilitated by tristetraprolin destabilization of Otud-6b mRNA through AU-rich motifs. Enforced expression of OTUD-6B in Ba/F3 cells could block cell proliferation by arresting cells in G1 phase. In addition, cyclin D2 level was down-regulated when OTUD-6B WT was overexpressed. Therefore, down-regulation of Otud-6b expression after prolonged cytokine stimulation may be required for cell proliferation in B lymphocytes. Citation: Xu Z, Zheng Y, Zhu Y, Kong X, Hu L Evidence for OTUD-6B Participation in B Lymphocytes Cell Cycle after Cytokine Stimulation. PLoS ONE 6: e14514. doi:10.1371/journal.pone.0014514 Editor: James G. Umen, The Salk Institute, United States of America Received July 20, 2010; Accepted November 30, 2010; Published January 18, 2011 Copyright: 2011 Xu 9373158 et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the origin
